pharmacie et médicaments – Réduction des remises commerciales sur les médicaments génériques

This written question concerns the potential reduction of commercial rebates applied to generic medicines in France. It seeks clarification on the implications for the pharmaceutical market and patient access to affordable treatments. The question addresses the impact on pharmaceutical companies, pharmacies, and ultimately, patients who rely on generic drugs for cost-effective healthcare.